Sagittarius Life Science Corp (TPEX:3205)

Market Cap	3.65B +369.9%
Revenue (ttm)	392.26M -13.2%
Net Income	-30.56M
EPS	-0.49
Shares Out	67.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	104,493
Open	54.20
Previous Close	54.20
Day's Range	53.70 - 54.40
52-Week Range	40.80 - 67.00
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 112
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 3205

Financial Performance

In 2025, Sagittarius Life Science's revenue was 346.08 million, a decrease of -26.01% compared to the previous year's 467.75 million. Losses were -49.56 million, 2.13% more than in 2024.